Atlas Trials

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

Clinical trial NCT06762470 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06762470
Sponsor
Jiangxi Provincial Cancer Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Histopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Start date
2025-01-01
Primary completion
2028-12-31
Enrollment
325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.